ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,735 | -13.0% | 19,613 | 0.0% | 0.02% | -11.5% |
| Q2 2023 | $469,731 | +27.3% | 19,613 | 0.0% | 0.03% | +44.4% |
| Q1 2023 | $369,117 | +18.2% | 19,613 | 0.0% | 0.02% | +12.5% |
| Q4 2022 | $312,239 | -2.7% | 19,613 | 0.0% | 0.02% | -27.3% |
| Q3 2022 | $321,000 | +16.3% | 19,613 | 0.0% | 0.02% | +29.4% |
| Q2 2022 | $276,000 | -41.9% | 19,613 | 0.0% | 0.02% | -19.0% |
| Q1 2022 | $475,000 | +3.7% | 19,613 | 0.0% | 0.02% | +31.2% |
| Q4 2021 | $458,000 | +40.5% | 19,613 | 0.0% | 0.02% | -33.3% |
| Q3 2021 | $326,000 | -31.8% | 19,613 | 0.0% | 0.02% | -25.0% |
| Q2 2021 | $478,000 | -5.5% | 19,613 | 0.0% | 0.03% | -8.6% |
| Q1 2021 | $506,000 | -51.8% | 19,613 | 0.0% | 0.04% | -39.7% |
| Q4 2020 | $1,049,000 | +29.7% | 19,613 | 0.0% | 0.06% | -41.4% |
| Q3 2020 | $809,000 | -14.9% | 19,613 | 0.0% | 0.10% | -38.9% |
| Q2 2020 | $951,000 | +14.7% | 19,613 | 0.0% | 0.16% | -16.1% |
| Q1 2020 | $829,000 | -1.2% | 19,613 | 0.0% | 0.19% | +18.4% |
| Q4 2019 | $839,000 | +18.8% | 19,613 | 0.0% | 0.16% | +12.4% |
| Q3 2019 | $706,000 | +34.7% | 19,613 | 0.0% | 0.14% | +30.6% |
| Q2 2019 | $524,000 | -0.6% | 19,613 | 0.0% | 0.11% | -16.5% |
| Q1 2019 | $527,000 | +121.4% | 19,613 | +33.1% | 0.13% | +70.5% |
| Q4 2018 | $238,000 | -22.2% | 14,732 | 0.0% | 0.08% | -1.3% |
| Q3 2018 | $306,000 | +36.0% | 14,732 | 0.0% | 0.08% | +21.5% |
| Q2 2018 | $225,000 | -65.2% | 14,732 | -48.7% | 0.06% | -4.4% |
| Q1 2018 | $646,000 | -30.9% | 28,736 | -7.4% | 0.07% | +28.3% |
| Q4 2017 | $935,000 | -59.0% | 31,046 | -48.7% | 0.05% | -37.6% |
| Q3 2017 | $2,280,000 | -32.8% | 60,532 | -50.2% | 0.08% | -6.6% |
| Q2 2017 | $3,393,000 | -47.2% | 121,653 | -35.0% | 0.09% | -54.5% |
| Q1 2017 | $6,431,000 | -8.7% | 187,055 | -23.4% | 0.20% | -6.5% |
| Q4 2016 | $7,040,000 | – | 244,121 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |